136 related articles for article (PubMed ID: 20360618)
1. Does nebivolol influence serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats?
Górska D; Dudarewicz M; Czarnecka E; Andrzejczak D
Pharmacol Rep; 2010; 62(1):86-94. PubMed ID: 20360618
[TBL] [Abstract][Full Text] [Related]
2. The effects of celiprolol on serum concentrations of proinflammatory cytokines in hypertensive (SHR) and normotensive (WKY) rats.
Andrzejczak D; Górska D
Pharmacol Rep; 2014 Feb; 66(1):68-73. PubMed ID: 24905309
[TBL] [Abstract][Full Text] [Related]
3. Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats.
Bertera FM; Del Mauro JS; Polizio AH; Chiappetta D; Taira CA; Höcht C
Naunyn Schmiedebergs Arch Pharmacol; 2012 Aug; 385(8):833-43. PubMed ID: 22566167
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats.
Toblli JE; Cao G; Casas G; Mazza ON
Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of nebivolol in spontaneously hypertensive rats persist after treatment withdrawal.
Guerrero EI; Ardanaz N; Sevilla MA; Arévalo MA; Montero MJ
J Hypertens; 2006 Jan; 24(1):151-8. PubMed ID: 16331113
[TBL] [Abstract][Full Text] [Related]
6. Influence of amlodipine and atenolol on lipopolysaccharide (LPS)-induced serum concentrations of TNF-alpha, IL-1, IL-6 in spontaneously hypertensive rats (SHR).
Andrzejczak D; Górska D; Czarnecka E
Pharmacol Rep; 2006; 58(5):711-9. PubMed ID: 17085863
[TBL] [Abstract][Full Text] [Related]
7. The l-enantiomer of nebivolol potentiates the blood pressure lowering effect of the d-enantiomer.
Xhonneux R; Wouters L; Reneman RS; Janssen PA
Eur J Pharmacol; 1990 Jun; 181(3):261-5. PubMed ID: 1974517
[TBL] [Abstract][Full Text] [Related]
8. Influence of enalapril, quinapril and losartan on lipopolysaccharide (LPS)-induced serum concentrations of TNF-alpha, IL-1 beta, IL-6 in spontaneously hypertensive rats (SHR).
Andrzejczak D; Górska D; Czarnecka E
Pharmacol Rep; 2007; 59(4):437-46. PubMed ID: 17901573
[TBL] [Abstract][Full Text] [Related]
9. Effect of nebivolol on endothelial nitric oxide and peroxynitrite release in hypertensive animals: Role of antioxidant activity.
Mason RP; Kubant R; Jacob RF; Walter MF; Boychuk B; Malinski T
J Cardiovasc Pharmacol; 2006 Jul; 48(1):862-9. PubMed ID: 16891916
[TBL] [Abstract][Full Text] [Related]
10. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
Wang Y; Zhang M; Liu Y; Liu Y; Chen M
Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of nebivolol.
Janssens WJ
J Pharm Belg; 1992; 47(4):323-7. PubMed ID: 1357130
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of nebivolol and hydrochlorothiazide combination in spontaneously hypertensive rats.
Wang Y; Evangelista S; Liu Y; Zhang MS
J Int Med Res; 2013 Jun; 41(3):603-17. PubMed ID: 23680668
[TBL] [Abstract][Full Text] [Related]
13. Long-term treatment with nebivolol improves arterial reactivity and reduces ventricular hypertrophy in spontaneously hypertensive rats.
Guerrero E; Voces F; Ardanaz N; Montero MJ; Arévalo M; Sevilla MA
J Cardiovasc Pharmacol; 2003 Sep; 42(3):348-55. PubMed ID: 12960679
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the sympatholytic action of nebivolol and hypotension.
Ward JE; Coles P; Cox H; Eisenhofer G; Angus JA
J Cardiovasc Pharmacol; 1992 Jul; 20(1):115-24. PubMed ID: 1383620
[TBL] [Abstract][Full Text] [Related]
15. Modulation of TNF-α, interleukin-6, and interleukin-10 by nebivolol-valsartan and nebivolol-lisinopril polytherapy in SHR rats.
Diego LM; Jazmin FM; Diana RH; German-Isauro GF; Salvador FC; Maria-Elena HC
Pharmacol Res Perspect; 2024 Apr; 12(2):e1189. PubMed ID: 38504425
[TBL] [Abstract][Full Text] [Related]
16. Effects of the selective beta 1-adrenoceptor antagonist, nebivolol, on cardiovascular parameters in the pithed normotensive rat.
Schneider J; Fruh C; Wilffert B; Peters T
Pharmacology; 1990; 40(1):33-41. PubMed ID: 1970437
[TBL] [Abstract][Full Text] [Related]
17. Effects of third-generation β-blockers, atenolol or amlodipine on blood pressure variability and target organ damage in spontaneously hypertensive rats.
Del Mauro JS; Prince PD; Allo MA; Santander Plantamura Y; Morettón MA; González GE; Bertera FM; Carranza A; Gorzalczany SB; Chiappetta DA; Morales C; Gelpi RJ; Taira CA; Polizio AH; Donato M; Höcht C
J Hypertens; 2020 Mar; 38(3):536-545. PubMed ID: 32028517
[TBL] [Abstract][Full Text] [Related]
18. Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats.
Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
Hypertens Res; 2014 Mar; 37(3):194-201. PubMed ID: 24132009
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure-lowering effect of nebivolol in hypertensive patients with type 2 diabetes mellitus: the YESTONO study.
Schmidt AC; Graf C; Brixius K; Scholze J
Clin Drug Investig; 2007; 27(12):841-9. PubMed ID: 18020542
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
Agabiti Rosei E; Rizzoni D
Drugs; 2007; 67(8):1097-107. PubMed ID: 17521213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
